Blog

New immunotherapy for lung cancer shows promise of success – SCNow


SCNow

New immunotherapy for lung cancer shows promise of success
SCNow
Patients who have stopped responding to checkpoint therapy might be helped significantly by adding ALT-803. Pre-clinical studies have shown that ALT-803 activates the immune system to mobilize lymphocytes against tumor cells and could potentially serve

2018-04-15 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.